Back to Journals » OncoTargets and Therapy » Volume 7

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Total article views   HTML views PDF downloads Totals
9,551 Dovepress* 8,619+ 1,407 10,026
PubMed Central* 932 364 1,296
Totals 9,551 1,771 11,322
*Since 8 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar